Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: Analysis of laser capture microdissected specimens

Laboratory Investigation

Volumn 81, Issue 3, 2001, Pages 283-288

  Takayama, Hitoshi ^a   Takakuwa, Tetsuya ^a   Dong, Zhiming ^a   Nonomura, Norio ^a   Okuyama, Akihiko ^a   Nagata, Shigekazu ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MISSENSE MUTATION; NONSENSE MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SEQUENCE ANALYSIS;

EID: 0035079876     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780236     Document Type: Article

References (31)

1. Laser capture microdissection: Molecular analysis of tissue
2. High grade prostatic intraepithelial neoplasia: The most likely precursor of prostatic cancer
3. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
4. Staging of prostate cancer
5. Characterization of human Fas gene: Exon/intron organization and promoter region
6. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma
7. Prostatic intraepithelial neoplasia (PIN) and invasive carcinoma in total prostatectomy specimens: Distribution, volumes, and DNA ploidy
8. Laser capture microdissection
9. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
10. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome
11. Loss of the chromosomal region 10q23-25 in prostate cancer
12. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
13. Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma
14. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer
15. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene
16. A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen
17. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
18. Mutations in the Fas antigen in patients with multiple myeloma
19. Alterations of Fas (Apo/CD95) gene in non-small cell lung cancer
20. Alterations of Fas (Apo/CD95) gene in transitional cell carcinoma of urinary bladder
21. Origins of prostate cancer
22. Apoptosis by death factor
23. The extent and multi-centricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma
24. Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases
25. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations
26. Extent and zonal distribution of prostatic carcinoma in Japan: Analysis of whole-mounted prostatectomy specimens
27. Prostatic intraepithelial neoplasia in surgical resections
28. Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival
29. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas
30. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
31. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen